Cargando…

Estimands for clinical endpoints in Tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial

BACKGROUND: Randomized trials for the treatment of tuberculosis (TB) rely on a composite primary outcome to capture unfavorable treatment responses. However, variability between trials in the outcome definition and estimation methods complicates across-trial comparisons and hinders the advancement o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weir, Isabelle R, Dufault, Suzanne M, Phillips, Patrick PJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659528/ https://www.ncbi.nlm.nih.gov/pubmed/37986887 http://dx.doi.org/10.21203/rs.3.rs-3486707/v1

Ejemplares similares

Rethinking intercurrent events in defining estimands for tuberculosis trials
por: Pham, Tra My, et al.
Publicado: (2022)

Estimands for factorial trials
por: Kahan, Brennan C., et al.
Publicado: (2022)

Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study
por: Rehal, Sunita, et al.
Publicado: (2023)

Translating questions to estimands in randomized clinical trials with intercurrent events
por: Stensrud, Mats J., et al.
Publicado: (2022)

Estimands: bringing clarity and focus to research questions in clinical trials
por: Clark, Timothy Peter, et al.
Publicado: (2022)

The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
por: Phillips, Patrick PJ, et al.
Publicado: (2011)

Estimands in cluster-randomized trials: choosing analyses that answer the right question
por: Kahan, Brennan C, et al.
Publicado: (2022)

Understanding estimands
por: Gogtay, Nithya Jaideep, et al.
Publicado: (2021)

Estimands in published protocols of randomised trials: urgent improvement needed
por: Kahan, Brennan C., et al.
Publicado: (2021)

Why estimands are needed to define treatment effects in clinical trials
por: Keene, Oliver N., et al.
Publicado: (2023)

Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example
por: Aroda, Vanita R., et al.
Publicado: (2019)

Functional Loss and Mortality in Randomized Clinical Trials for Amyotrophic Lateral Sclerosis: To Combine, or Not to Combine—That is the Estimand
por: van Eijk, Ruben P.A., et al.
Publicado: (2022)

Marking 2-Years of New Thinking in Clinical Trials: The Estimand Journey
por: Fletcher, C., et al.
Publicado: (2022)

Re-randomisation trials in multi-episode settings: Estimands and independence estimators
por: Kahan, Brennan C, et al.
Publicado: (2022)

Estimands and Complex Innovative Designs
por: Collignon, Olivier, et al.
Publicado: (2022)

Estimands in epigenome-wide association studies
por: Kruppa, Jochen, et al.
Publicado: (2021)

Estimands—What they are and why they are important for pharmacometricians
por: Akacha, Mouna, et al.
Publicado: (2021)

Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions
por: Kahan, Brennan C., et al.
Publicado: (2020)

Evaluating how clear the questions being investigated in randomised trials are: systematic review of estimands
por: Cro, Suzie, et al.
Publicado: (2022)

Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods
por: Olarte Parra, Camila, et al.
Publicado: (2022)

Eliminating Ambiguous Treatment Effects Using Estimands
por: Kahan, Brennan C, et al.
Publicado: (2023)

Commentary: Estimands in cluster trials: thinking carefully about the target of inferenceand the consequences for analysis choice
por: Hemming, Karla, et al.
Publicado: (2022)

Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
por: Nixon, Richard M, et al.
Publicado: (2003)

Some considerations on target estimands for health technology assessment
por: Remiro‐Azócar, Antonio
Publicado: (2022)

A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials
por: Hills, N. K., et al.
Publicado: (2021)

Beyond “Intent‐to‐treat” and “Per protocol”: Improving assessment of treatment effects in clinical trials through the specification of an estimand
por: Pétavy, Frank, et al.
Publicado: (2020)

Statistical methods and graphical displays of quality of life with survival outcomes in oncology clinical trials for supporting the estimand framework
por: Sakamaki, Kentaro, et al.
Publicado: (2022)

Defining Clinical Trial Estimands: A Practical Guide for Study Teams with Examples Based on a Psychiatric Disorder
por: Polverejan, Elena, et al.
Publicado: (2023)

Starting a conversation about estimands with public partners involved in clinical trials: a co-developed tool
por: Cro, Suzie, et al.
Publicado: (2023)

Estimands to quantify prolonged hospital stay associated with nosocomial infections
por: Wolkewitz, Martin, et al.
Publicado: (2019)

Principles and recommendations for incorporating estimands into clinical study protocol templates
por: Lynggaard, Helle, et al.
Publicado: (2022)

A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis
por: Bratton, Daniel J, et al.
Publicado: (2013)

What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?
por: Lawrance, Rachael, et al.
Publicado: (2020)

Informative noncompliance in endpoint trials
por: Snapinn, Steven M, et al.
Publicado: (2004)

Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology
por: Serpas, Victoria J., et al.
Publicado: (2018)

PNS250 How to Deal with COVID-19-Related Intercurrent Events on Trial Estimands for Patient-Reported Outcomes (PRO) Objectives
por: Skaltsa, K., et al.
Publicado: (2020)

Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data
por: Wharton, Sean, et al.
Publicado: (2021)

Endpoints used in phase III randomized controlled trials of treatment options for COVID-19
por: Desai, Aakash, et al.
Publicado: (2020)

Improved Endpoints for Cancer Immunotherapy Trials
por: Hoos, Axel, et al.
Publicado: (2010)

IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jmj0vdo0tn07u1lihg81gf981r